Abstract: The creation of new heterocyclic scaffolds with improved pharmacological profiles has become necessary due to the growing global problem of multi-drug resistant (MDR) bacterial strains. In this investigation, a number of unique 2-(5-(3,5-bis(trifluoromethyl)phenyl)The in vitro antibacterial potential of -1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5-(alkylthio)-1,3,4-oxadiazole derivatives (6a–h) was carefully planned, produced, and assessed. The biologically powerful pyrazole and 1,3,4-oxadiazole nuclei were integrated into the molecular architecture of these hybrids, and fluorine-rich pharmacophores were then added to maximize lipophilicity and metabolic stability.The synthesis procedure produced a 1,3-diketoester intermediate by Claisen condensation of 3,5-bis(trifluoromethyl)acetophenone with diethyl oxalate. A combination of positional isomers (3a and 3b) was obtained via cyclization with 4-fluorophenyl hydrazine hydrochloride. The distinction of these isomers using $^1$H NMR spectroscopy, where the magnetic anisotropy of the 4-fluorophenyl ring verified the shielding of the bis-trifluoromethyl phenyl protons in the major isomer 3a, was an important analytical discovery of this work. A carbohydrazide intermediate was used to convert 3a into the 1,3,4-oxadiazole-2-thiol scaffold. The final library was then obtained by nucleophilic S-alkylation with different alkyl halides.
Several compounds have strong inhibitory activity, according to the antimicrobial screening against a panel of Gram-positive and Gram-negative microorganisms. With a Minimum Inhibitory Concentration (MIC) of 12.5 $\mu$g/mL against Pseudomonas aeruginosa—two times more effective than the reference standard, chloramphenicol (MIC 25 $\mu$g/mL)—the parent thio-oxadiazole intermediate 5 stood out as a particularly strong lead. Increasing the length of the S-alkyl side chain (such as n-butyl and allyl groups) is correlated with improved antibacterial activity, according to Structure-Activity Relationship (SAR) studies. These results highlight the trifluoromethyl-substituted heterocyclic hybrids' potential as viable options for the creation of antimicrobial agents of the future.
Keywords: Pyrazole, 1,3,4-Oxadiazole, Trifluoromethyl, Antimicrobial Activity, MIC, Isomeric Shielding, S-Alkylation.
Title: Molecular Hybridization Strategies for the Synthesis of Novel Fluorinated Pyrazole-1,3,4-Oxadiazole S-Alkyl Hybrids: Regioselective Construction and Evaluation as Potential Antimicrobial Leads
Author: Kashi Ram, Dr Narendra Singh, Teja Ram, Dr Ritika Dadhich, Babu Lal Patel
International Journal of Interdisciplinary Research and Innovations
ISSN 2348-1218 (print), ISSN 2348-1226 (online)
Vol. 14, Issue 2, April 2026 - June 2026
Page No: 17-28
Research Publish Journals
Website: www.researchpublish.com
Published Date: 15-April-2026
